vs

Side-by-side financial comparison of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) and Beauty Health Co (SKIN). Click either name above to swap in a different company.

Beauty Health Co is the larger business by last-quarter revenue ($82.4M vs $66.7M, roughly 1.2× INNOVATIVE INDUSTRIAL PROPERTIES INC). INNOVATIVE INDUSTRIAL PROPERTIES INC runs the higher net margin — 47.8% vs -9.8%, a 57.6% gap on every dollar of revenue. On growth, Beauty Health Co posted the faster year-over-year revenue change (-1.3% vs -13.1%). Over the past eight quarters, Beauty Health Co's revenue compounded faster (0.6% CAGR vs -6.0%).

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.

IIPR vs SKIN — Head-to-Head

Bigger by revenue
SKIN
SKIN
1.2× larger
SKIN
$82.4M
$66.7M
IIPR
Growing faster (revenue YoY)
SKIN
SKIN
+11.8% gap
SKIN
-1.3%
-13.1%
IIPR
Higher net margin
IIPR
IIPR
57.6% more per $
IIPR
47.8%
-9.8%
SKIN
Faster 2-yr revenue CAGR
SKIN
SKIN
Annualised
SKIN
0.6%
-6.0%
IIPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IIPR
IIPR
SKIN
SKIN
Revenue
$66.7M
$82.4M
Net Profit
$31.8M
$-8.1M
Gross Margin
64.4%
Operating Margin
47.8%
0.2%
Net Margin
47.8%
-9.8%
Revenue YoY
-13.1%
-1.3%
Net Profit YoY
-20.4%
21.5%
EPS (diluted)
$1.07
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIPR
IIPR
SKIN
SKIN
Q4 25
$66.7M
$82.4M
Q3 25
$64.7M
$70.7M
Q2 25
$62.9M
$78.2M
Q1 25
$71.7M
$69.6M
Q4 24
$76.7M
$83.5M
Q3 24
$76.5M
$78.8M
Q2 24
$79.8M
$90.6M
Q1 24
$75.5M
$81.4M
Net Profit
IIPR
IIPR
SKIN
SKIN
Q4 25
$31.8M
$-8.1M
Q3 25
$29.3M
$-11.0M
Q2 25
$26.0M
$19.7M
Q1 25
$31.1M
$-10.1M
Q4 24
$40.0M
$-10.3M
Q3 24
$40.2M
$-18.3M
Q2 24
$42.0M
$202.0K
Q1 24
$39.4M
$-679.0K
Gross Margin
IIPR
IIPR
SKIN
SKIN
Q4 25
64.4%
Q3 25
64.6%
Q2 25
62.8%
Q1 25
69.8%
Q4 24
62.7%
Q3 24
51.6%
Q2 24
45.2%
Q1 24
59.4%
Operating Margin
IIPR
IIPR
SKIN
SKIN
Q4 25
47.8%
0.2%
Q3 25
45.5%
-8.8%
Q2 25
45.9%
-3.5%
Q1 25
47.4%
-17.3%
Q4 24
54.7%
-8.6%
Q3 24
54.8%
-27.3%
Q2 24
53.1%
-24.4%
Q1 24
55.7%
-20.9%
Net Margin
IIPR
IIPR
SKIN
SKIN
Q4 25
47.8%
-9.8%
Q3 25
45.3%
-15.6%
Q2 25
41.4%
25.2%
Q1 25
43.3%
-14.5%
Q4 24
52.2%
-12.4%
Q3 24
52.6%
-23.2%
Q2 24
52.6%
0.2%
Q1 24
52.3%
-0.8%
EPS (diluted)
IIPR
IIPR
SKIN
SKIN
Q4 25
$1.07
$-0.02
Q3 25
$0.97
$-0.09
Q2 25
$0.86
$0.03
Q1 25
$1.03
$-0.08
Q4 24
$1.35
$-0.01
Q3 24
$1.37
$-0.15
Q2 24
$1.44
$-0.10
Q1 24
$1.36
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIPR
IIPR
SKIN
SKIN
Cash + ST InvestmentsLiquidity on hand
$47.6M
Total DebtLower is stronger
$393.7M
Stockholders' EquityBook value
$1.8B
$61.1M
Total Assets
$2.4B
$499.8M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIPR
IIPR
SKIN
SKIN
Q4 25
$47.6M
Q3 25
$41.9M
Q2 25
$104.9M
Q1 25
$133.3M
Q4 24
$151.2M
Q3 24
$172.4M
Q2 24
$160.9M
Q1 24
$173.5M
Total Debt
IIPR
IIPR
SKIN
SKIN
Q4 25
$393.7M
Q3 25
$363.4M
Q2 25
$363.1M
Q1 25
Q4 24
$552.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IIPR
IIPR
SKIN
SKIN
Q4 25
$1.8B
$61.1M
Q3 25
$1.9B
$65.7M
Q2 25
$1.9B
$74.0M
Q1 25
$1.9B
$46.1M
Q4 24
$1.9B
$51.8M
Q3 24
$1.9B
$59.7M
Q2 24
$1.9B
$69.2M
Q1 24
$2.0B
$63.3M
Total Assets
IIPR
IIPR
SKIN
SKIN
Q4 25
$2.4B
$499.8M
Q3 25
$2.3B
$503.6M
Q2 25
$2.3B
$507.6M
Q1 25
$2.4B
$673.8M
Q4 24
$2.4B
$685.7M
Q3 24
$2.4B
$699.5M
Q2 24
$2.4B
$711.8M
Q1 24
$2.4B
$844.7M
Debt / Equity
IIPR
IIPR
SKIN
SKIN
Q4 25
0.21×
Q3 25
5.53×
Q2 25
4.91×
Q1 25
Q4 24
10.66×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIPR
IIPR
SKIN
SKIN
Operating Cash FlowLast quarter
$198.2M
$15.2M
Free Cash FlowOCF − Capex
$15.1M
FCF MarginFCF / Revenue
18.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
6.22×
TTM Free Cash FlowTrailing 4 quarters
$37.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIPR
IIPR
SKIN
SKIN
Q4 25
$198.2M
$15.2M
Q3 25
$45.6M
$9.6M
Q2 25
$48.4M
$9.6M
Q1 25
$54.2M
$3.0M
Q4 24
$258.4M
$16.5M
Q3 24
$64.9M
$10.3M
Q2 24
$64.2M
$6.2M
Q1 24
$71.6M
$-16.9M
Free Cash Flow
IIPR
IIPR
SKIN
SKIN
Q4 25
$15.1M
Q3 25
$9.6M
Q2 25
$9.6M
Q1 25
$3.0M
Q4 24
$16.4M
Q3 24
$10.3M
Q2 24
$5.9M
Q1 24
$-17.2M
FCF Margin
IIPR
IIPR
SKIN
SKIN
Q4 25
18.3%
Q3 25
13.6%
Q2 25
12.2%
Q1 25
4.2%
Q4 24
19.6%
Q3 24
13.1%
Q2 24
6.5%
Q1 24
-21.1%
Capex Intensity
IIPR
IIPR
SKIN
SKIN
Q4 25
0.2%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.4%
Q1 24
0.4%
Cash Conversion
IIPR
IIPR
SKIN
SKIN
Q4 25
6.22×
Q3 25
1.56×
Q2 25
1.86×
0.49×
Q1 25
1.75×
Q4 24
6.46×
Q3 24
1.61×
Q2 24
1.53×
30.70×
Q1 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIPR
IIPR

Segment breakdown not available.

SKIN
SKIN

Consumables$57.7M70%
Delivery Systems$24.7M30%

Related Comparisons